Table 3 The result of cost ($US) simulation of genetic screening tests for the genetic strategies
From: A cost-benefit analysis of genetic screening test for breast cancer in Iran
Cost items | Costs for population-based screening strategy | % of total cost | Costs for FH-based screening strategy | % of total cost |
|---|---|---|---|---|
Genetic counseling and genetic screening BRCA tests | 350,420,813 | 96.36 | 7,202,469 | 40.64 |
Preventive surgical interventions and associated costs | 4,280,310 | 1.18 | 1,715,237 | 9.68 |
Preventive interventions (mammography and annual MRI) | 68,157 | 0.02 | 27,312 | 0.15 |
Total direct medical costs | 354,769,280 | 97.56 | 8,945,018 | 50.47 |
Total direct non-medical costs | 8,881,488 | 2.44 | 8,777,327 | 49.53 |
Total direct medical and non-medical costs | 363,650,768 | 100 | 17,722,345 | 100 |
Number of people entered into the models | 2,176,919 | 2,176,919 | ||
Number of high-risk individuals identified | 12,271 | 4,917 | ||
Cost per screening | 167.05 | 8.14 | ||